Health Care & Life Sciences » Biotechnology | Vertex Pharmaceuticals Inc.

Vertex Pharmaceuticals Inc.

Vertex Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
255.56 M
Public Float
226.28 M
Vertex Pharmaceuticals Inc.
Stock Exchange Mexican Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
255.56 M
Public Float
226.28 M
Vertex Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$8.3
Market Cap
$45.68 B
Shares Outstanding
256.12 M
Public Float
255.16 M

Profile

Address
50 Northern Avenue
Boston Massachusetts 02210
United States
Employees -
Website http://www.vrtx.com
Updated 07/08/2019
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S.

Financials

View All

Jeffrey M. Leiden
Chairman, President & Chief Executive Officer
Alan M. Garber
Independent Director